Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGS:DDOG
NasdaqGS:DDOGSoftware

Datadog (DDOG) Q4 Margins At 3.1% Test Bullish Profitability Narratives

Datadog (DDOG) has wrapped up FY 2025 with fourth quarter revenue of US$953.2 million and basic EPS of US$0.13, alongside net income of US$46.6 million. This puts a clear spotlight on how its topline and per share earnings are tracking as the year closes out. Over the past six quarters, revenue has moved from US$690.0 million in Q3 2024 to US$953.2 million in Q4 2025. Over the same period, quarterly basic EPS has ranged from US$0.15 in Q3 2024 to US$0.01 in Q2 2025 and then to US$0.13 in the...
NasdaqGS:FRD
NasdaqGS:FRDMetals and Mining

Friedman Industries (FRD) Q3 2026 Net Margin Improvement Tests Bearish Cash Flow Narratives

Friedman Industries Q3 2026 Earnings Snapshot Friedman Industries (FRD) has reported Q3 2026 results with total revenue of US$168.0 million, net income of US$3.0 million and basic EPS of US$0.43, setting the tone for another data heavy quarter for investors to assess. The company has seen quarterly revenue move from US$106.8 million in Q2 2025 to US$94.1 million in Q3 2025, then to US$129.2 million in Q4 2025, US$134.8 million in Q1 2026, US$152.4 million in Q2 2026 and US$168.0 million in Q3...
TSE:6674
TSE:6674Auto Components

GS Yuasa (TSE:6674) Is Up 22.5% After Raising Profit Outlook and Dividend Forecast - What's Changed

In February 2026, GS Yuasa Corporation reported nine-month results to December 31, 2025, with sales of ¥432,983 million, net income of ¥22,071 million, and basic earnings per share from continuing operations of ¥220.03. At the same time, the company lifted its year-end dividend forecast to ¥60.00 per share and raised its full-year profit outlook, signaling management confidence in its ongoing performance and cash generation. Building on this upward revision to profit guidance, we will now...
NasdaqGS:ARWR
NasdaqGS:ARWRBiotechs

Arrowhead Joins S&P 400 As Profitability Shifts Investor Focus

Arrowhead Pharmaceuticals (NasdaqGS:ARWR) has been added to the S&P 400 index and its related sector indices. At the same time, the company has been removed from the S&P 600 index, shifting its classification within the S&P family. This index change reflects a reclassification of Arrowhead's market standing and may affect how index funds and ETFs hold the stock. Arrowhead Pharmaceuticals focuses on RNA interference based therapies, an area that has attracted steady attention as drug...
NasdaqGS:FSLY
NasdaqGS:FSLYIT

How Analyst Optimism on Traffic and Pricing Trends Will Impact Fastly (FSLY) Investors

In the past week, Fastly drew attention ahead of its latest earnings release, with analysts reiterating forecasts after the company previously reported US$158.2 million in quarterly revenue, up 15.3% year on year and above expectations. Recent analyst commentary has highlighted steady estimates, a generally cautious but positive tone on traffic growth and pricing, and Fastly’s record of usually meeting or beating revenue forecasts as key reasons investors are closely watching the upcoming...
TSE:7012
TSE:7012Machinery

Kawasaki Heavy Industries Q3 EPS Surge Tests Bullish Growth Narratives

Kawasaki Heavy Industries (TSE:7012) has reported a busy Q3 2026 scorecard, with revenue at about ¥565.1 billion and Basic EPS of ¥261.79, supported by net income of ¥43,764 million. The company’s revenue has moved from roughly ¥439.9 billion in Q2 2025 to ¥523.2 billion in Q3 2025 and then to ¥565.1 billion in Q3 2026. Over the same periods, quarterly Basic EPS shifted from a loss of ¥10.20 in Q2 2025 to ¥182.03 in Q3 2025 and ¥261.79 in the latest quarter. These figures may encourage...
NasdaqGS:GT
NasdaqGS:GTAuto Components

Goodyear Tire & Rubber (GT) Q4 Profitability Rebound Tests Bearish Loss And Debt Narratives

Goodyear Tire & Rubber (GT) has wrapped up FY 2025 with fourth quarter revenue of US$4.9 billion and basic EPS of US$0.36, alongside net income excluding extra items of US$105 million. This sets a clear marker after a volatile year for earnings. Over the past six quarters, revenue has moved in a relatively tight band between US$4.3 billion and just under US$5.0 billion. Quarterly basic EPS has swung from a loss of US$7.62 in Q3 2025 to positive readings in Q1, Q2 and Q4, giving you a mixed...
TSE:6651
TSE:6651Electrical

Nitto Kogyo (TSE:6651) Q3 EPS Jump Tests Views On Margin And Valuation Risks

Nitto Kogyo (TSE:6651) has just posted Q3 2026 results with revenue of ¥54,058 million and net income of ¥4,618 million, translating to basic EPS of ¥121.72. The company’s revenue moved from ¥51,371 million in Q3 2025 to ¥54,058 million in Q3 2026, while basic EPS shifted from ¥100.22 to ¥121.72 over the same period, giving investors a clearer view of how the latest quarter fits into its recent earnings run. With trailing net profit margins softer than a year ago, this set of numbers puts the...
TSE:1929
TSE:1929Construction

Nittoc Construction (TSE:1929) Net Margin Jump To 5% Challenges Cautious Growth Narratives

Nittoc Construction (TSE:1929) has reported a solid Q3 2026 result, with revenue of ¥23.5b and net income of ¥1.9b translating into basic EPS of ¥44.43, supported by trailing twelve month revenue of ¥78.7b and EPS of ¥93.40. The company’s revenue increased from ¥20.4b to ¥23.5b and basic EPS rose from ¥31.40 to ¥44.43 when comparing the latest quarter with the same period a year ago. This sets up a story in which higher net profit margins and earnings growth are viewed alongside more modest...
NYSE:MAS
NYSE:MASBuilding

Masco (MAS) Margins Hold Near 10.7% And Reinforce Earnings Resilience Narrative

Masco (MAS) closed out FY 2025 with fourth quarter revenue of US$1.8 billion and basic EPS of US$0.81, alongside net income of US$165 million, setting the tone for how the full year’s performance lands with investors. Over the past four quarters, the company has seen revenue move from US$7.8 billion on a trailing basis in Q4 2024 to US$7.6 billion in Q4 2025, while trailing EPS shifted from US$3.77 to US$3.88. This provides a clear view of how the top and bottom lines have been tracking...
NYSE:LUMN
NYSE:LUMNTelecom

Lumen Technologies (LUMN) Is Down 8.0% After New CRO Hire And Ongoing Losses Reported

Lumen Technologies recently appointed former Cisco executive Jeff Sharritts as Executive Vice President and Chief Revenue Officer, while also reporting fourth-quarter 2025 sales of US$3,041 million and a net loss of US$2 million, alongside full-year 2025 sales of US$12.40 billion and a net loss of US$1.74 billion. This combination of a high-profile commercial leadership change and a move from prior profitability to continued losses highlights both execution challenges and efforts to reshape...
NasdaqGS:TEAM
NasdaqGS:TEAMSoftware

Cramer Applauds Atlassian Earnings While Insider Sales Test Growth Story

Jim Cramer recently highlighted Atlassian (NasdaqGS:TEAM) as a potentially undervalued software stock after a strong earnings beat and updated company guidance. The company reported results that outperformed expectations and management issued improved guidance, drawing positive attention from market commentators and analysts. At the same time, insider selling activity at Atlassian has picked up, which may prompt questions about how insiders view the current share price. The mix of public...
NasdaqGS:ENTA
NasdaqGS:ENTABiotechs

Enanta Pharmaceuticals (ENTA) Quarterly Loss Narrows Yet Keeps Profitability Concerns In Investor Focus

Enanta Pharmaceuticals Q1 2026 Earnings Snapshot Enanta Pharmaceuticals (ENTA) opened its 2026 financial year with Q1 revenue of US$18.6 million and a basic EPS loss of US$0.42, alongside a net income loss of US$11.9 million, setting a clear tone for where the business is today. The company has seen quarterly revenue fluctuate in a tight band between US$14.6 million and US$18.6 million over the last six reported periods, while basic EPS losses have ranged from about US$0.42 to US$1.36. This...
NYSE:CTS
NYSE:CTSElectronic

CTS (CTS) Margin Improvement Tests Bullish Narratives After FY 2025 Earnings

CTS (CTS) just closed out FY 2025 with fourth quarter revenue of US$137.3 million and basic EPS of US$0.68, capping a trailing twelve month run of US$541.3 million in revenue and EPS of US$2.21 that has supported 12.4% earnings growth over the past year. Over the last few quarters, revenue has moved from US$127.4 million in Q4 2024 to US$137.3 million in Q4 2025, while quarterly EPS has shifted from US$0.45 to US$0.68, against a backdrop of net margins stepping up from 11.3% to 12.1%...
TSX:BCE
TSX:BCETelecom

How BCE’s 2026 Revenue Guidance and Dividend Update At BCE (TSX:BCE) Has Changed Its Investment Story

BCE Inc. previously reported fourth-quarter 2025 revenue of CA$6,404 million and net income of CA$630 million, with full-year 2025 revenue of CA$24,468 million and net income of CA$6.46 billion, while its board declared a quarterly dividend of CA$0.4375 per share payable on April 15, 2026. Alongside these results, BCE issued 2026 guidance calling for 1% to 5% revenue growth, giving investors a clearer view of management’s expectations for the year ahead. We’ll now assess how BCE’s 2026...
TSE:1979
TSE:1979Construction

Taikisha (TSE:1979) Valuation In Focus As Board Weighs Treasury Share Disposal By Third Party Allotment

Taikisha (TSE:1979) has called a board meeting for February 10, 2026 to consider a resolution on disposing of treasury shares through a third-party allotment. This move could reshape its shareholder mix. See our latest analysis for Taikisha. That board meeting comes on the back of strong momentum, with Taikisha’s share price at ¥3,815 and a 90 day share price return of 20.73%, while the 1 year total shareholder return of 64.35% indicates that interest has been building over time. If this...
NasdaqGS:MTSI
NasdaqGS:MTSISemiconductor

Why MACOM Technology Solutions (MTSI) Is Up 7.2% After Returning To Profit And Raising Revenue Guidance

In the first quarter ended January 2, 2026, MACOM Technology Solutions Holdings reported sales of US$271.61 million and net income of US$48.77 million, reversing a prior-year net loss and turning last year’s loss per share from continuing operations into earnings of US$0.64–US$0.65. Alongside this sharp swing back to profitability, MACOM issued revenue guidance of US$281 million to US$289 million for the April 3, 2026 quarter, signaling management confidence after a period of weaker...
NYSE:LUV
NYSE:LUVAirlines

A Look At Southwest Airlines (LUV) Valuation As Board Seats Change And Directors Prepare To Exit

Southwest Airlines (LUV) is back in focus after Directors C. David Cush and Gregg A. Saretsky submitted their resignations from the Board, and the company plans to shrink the Board to 11 members. See our latest analysis for Southwest Airlines. Those board changes come after a busy few weeks for Southwest Airlines, including its latest earnings release, 2026 guidance and a reaffirmed quarterly dividend, all against a strong run in the shares. The current share price of $54.07 sits on top of a...
TSE:9033
TSE:9033Transportation

Hiroshima Electric Railway (TSE:9033) One Off Gain Skews Earnings And Challenges Bullish Narratives

Hiroshima Electric RailwayLtd (TSE:9033) posted Q3 2026 revenue of ¥8,828 million with a basic EPS loss of ¥1.35, while trailing 12 month basic EPS sat at ¥57.67 on revenue of ¥33,959 million and net income of ¥1,752 million, helped by a ¥2.1 billion one off gain and a net margin of 5.2%. Over recent quarters the company has seen revenue move from ¥8,372 million in Q2 2025 to ¥8,090 million in Q3 2025, then to ¥9,246 million in Q4 2025, followed by ¥7,889 million, ¥7,996 million and ¥8,828...
NasdaqGS:PHVS
NasdaqGS:PHVSPharmaceuticals

What Pharvaris (PHVS)'s New Deucrictibant Phase 3 and Platform Data Wave Means For Shareholders

Pharvaris recently announced that six abstracts featuring its lead candidate deucrictibant for hereditary angioedema, including first-time pivotal Phase 3 RAPIDe-3 data and final Phase 2 CHAPTER-1 results, were accepted for poster presentation at the 2026 American Academy of Allergy, Asthma & Immunology Annual Meeting. This wave of data disclosures, spanning on-demand treatment, prophylaxis, and an extended-release tablet formulation, concentrates investor attention on Pharvaris’s effort to...
NYSE:BBY
NYSE:BBYSpecialty Retail

Is It Time To Reassess Best Buy (BBY) After Its Mixed Share Price Performance?

If you are looking at Best Buy and wondering whether the recent share price tells the full story about its value, you are not alone. The stock closed at US$68.04, with a 3.8% gain over the last 7 days, a 3.6% decline over 30 days, a 1.6% decline year to date, and an 18.5% decline over 1 year. The 3 year and 5 year returns sit at 11.0% and 30.2% declines respectively. These mixed returns have kept investors focused on how the market is reacting to ongoing shifts in consumer electronics demand...
ASX:WDS
ASX:WDSOil and Gas

Is Woodside Energy Group (ASX:WDS) Price Justified After Recent Share Gains?

If you are looking at Woodside Energy Group and wondering whether the current share price really lines up with its underlying value, you are not alone. The stock last closed at A$25.93, with returns of 3.5% over 7 days, 9.9% over 30 days, 9.6% year to date and 13.1% over 1 year. Over longer periods, the 3 year return sits at a 10.1% decline and the 5 year return at 43.1%. These mixed returns across different timeframes give useful context for anyone trying to connect the share price with the...
NYSE:DUK
NYSE:DUKElectric Utilities

Duke Energy (DUK) Q4 Margin Resilience Reinforces Income Focused Narratives

Duke Energy FY 2025 Earnings Snapshot Duke Energy (DUK) has just wrapped up FY 2025 with Q4 revenue of US$7.9b and basic EPS of US$1.50, while its trailing twelve month figures came in at US$32.2b of revenue and EPS of US$6.32, supported by net income from ongoing operations of US$4.9b. Over recent quarters, the company has seen revenue move from US$6.9b in Q4 2024 to US$7.9b in Q4 2025, with quarterly EPS ranging between US$1.25 and US$1.81 during FY 2025. This sets up a story where...